Ferguson Enterprises Inc. Common Stock vs Kymera Therapeutics Inc. Common Stock — how do they compare? Ferguson Enterprises Inc. Common Stock trades at $222 (market cap $43.11B), while Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.87B). The key difference: Ferguson Enterprises Inc. Common Stock is far larger — about 4.9× Kymera Therapeutics Inc. Common Stock's market cap, and Ferguson Enterprises Inc. Common Stock pays a 1.6% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ferguson Enterprises Inc. Common Stock for 0 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| FERG | KYMR | |
|---|---|---|
Market Cap | $43.11B | $8.87B |
Volume | 945,793 | 779,107 |
Sector | Industrials | Health |
52-Week High | $267.71 | $127.31 |
52-Week Low | $214.26 | $55.80 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $49.56B | $8.26B |
Dividend Yield | 1.6% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Ferguson Enterprises, Inc. distributes plumbing, HVAC, waterworks, and related building products to professional contractors, builders, and facility managers across North America, operating through branches, showrooms, and digital commerce.
Read more on FERG →Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →